Blastic Plasmacytoid Dendritic Cell Neoplasm Clinical Presentation and Diagnosis

Affiliation auteursAffiliation ok
TitreBlastic Plasmacytoid Dendritic Cell Neoplasm Clinical Presentation and Diagnosis
Type de publicationJournal Article
Year of Publication2020
AuteursDeconinck E, Petrella T, Ottou FGarnache
JournalHEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume34
Pagination491-500
Date PublishedJUN
Type of ArticleArticle
ISSN0889-8588
Mots-clésAnatomopathology, BPDCN, Clinical presentation, Diagnosis, Immunophenotyping, Morphologies
Résumé

Clinical and biological presentation of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) is depicted to highlight criteria that might alert physicians. Diagnosis of BPDCN is still challenging and requires (1) immunophenotyping of blood or bone marrow aspiration using several markers (CD4, CD56, HLA-DR, myeloid and lymphoid lineage markers) and should include pDC markers such as CD123, cTCL1, CD303, and CD304, and/or (2) pathologic analysis of cutaneous lesions, also with immunohistochemistry using markers specific to BPDCN.

DOI10.1016/j.hoc.2020.01.010